Article Details
Retrieved on: 2025-09-24 22:35:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Data at ECTRIMS will help back fenebrutinib as a potential addition to Roche's arsenal of drugs, and help cement Ocrevus's standing.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here